22 results match your criteria: "Service d'Anesthésie-Réanimation Centre Hospitalier Victor Provo[Affiliation]"
Ther Adv Med Oncol
September 2023
Service de Pneumologie-Oncologie Thoracique, Institut Cœur Poumon, Lille University Hospital, Lille, France.
Background: The optimal duration of immune checkpoint inhibitor (ICI) treatment for patients with advanced non-small cell lung cancer (NSCLC) remains to be determined. Treatment durations in cornerstone phase 3 clinical trials vary between a fixed 2-year duration and pursuit until disease progression. Clinical practices may thus differ according to the attending physician.
View Article and Find Full Text PDFBlood
April 2020
Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Service de Médecine Interne, Paris, France.
Scleromyxedema is a rare skin and systemic mucinosis that is usually associated with monoclonal gammopathy (MG). In this French multicenter retrospective study of 33 patients, we investigated the clinical and therapeutic features of MG-associated scleromyxedema. Skin molecular signatures were analyzed using a transcriptomic approach.
View Article and Find Full Text PDFAllergy
May 2019
Pediatric Respiratory Disease and Allergy Unit, Hospital, UNIROUEN, Inserm EA 2656, Rouen University Hospital, Normandie Univ, Rouen, France.
Rev Mal Respir
September 2017
Service de pneumologie, centre de compétences pour les maladies pulmonaires rares, hôpital Avicenne, CHU Paris-Seine-Saint-Denis, Bobigny, France.
Rev Mal Respir
October 2017
Service de pneumologie, centre de compétences pour les maladies pulmonaires rares, hôpital Avicenne, CHU Paris-Seine-Saint-Denis, Bobigny, France.
Rev Mal Respir
October 2017
Service de pneumologie, centre de compétences pour les maladies pulmonaires rares, hôpital Avicenne, CHU Paris-Seine-Saint-Denis, Bobigny, France.
Rev Mal Respir
September 2017
Service de pneumologie, centre de compétences pour les maladies pulmonaires rares, hôpital Avicenne, CHU Paris-Seine-Saint-Denis, Bobigny, France.
Rev Mal Respir
September 2017
Service de pneumologie, centre de compétences pour les maladies pulmonaires rares, hôpital Avicenne, CHU Paris-Seine-Saint-Denis, Bobigny, France.
Rev Mal Respir
October 2017
Service de pneumologie, centre de compétences pour les maladies pulmonaires rares, hôpital Avicenne, CHU Paris-Seine-Saint-Denis, Bobigny, France.
Clin Microbiol Infect
August 2017
Univ. Lille, Lille Inflammation Research International Center, Lille, France; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre National de Référence Maladies Systémiques et Auto-immunes Rares, Lille, France; CHU Lille, Institut d'Immunologie, Lille, France. Electronic address:
Objectives: Screening for primary immunodeficiencies (PIDs) in adults is recommended after two severe bacterial infections. We aimed to evaluate if screening should be performed after the first invasive infection in young adults.
Methods: Eligible patients were retrospectively identified using hospital discharge and bacteriology databases in three centres during a 3-year period.
Rev Pneumol Clin
May 2016
Service de pneumologie, hôpital Émile-Muller, 20, avenue du Dr-René-Laennec, 68070 Mulhouse, France.
Introduction: The French college of general hospital respiratory physicians (CPHG) has conducted 10 years apart two prospective observational studies to assess changes in the primary lung cancer epidemiology and outcomes, including 1-year mortality.
Methods: In 2000 and 2010, all volunteer adult patients followed in the respiratory department of general hospitals participating in the study were consecutively included if their lung cancer was histologically or cytologically diagnosed between 01 January and 31 December (sample date). Their vital status at least 1 year after inclusion and date of death (if applicable) were collected.
Cardiovasc J Afr
May 2015
Department of Molecular Genetics, Fondazione Salvatore Maugeri, IRCCS, Pavia, Italy; Department of Molecular Medicine, University of Pavia, Italy.
Background: The estimated rate of sudden cardiac death (SCD) in Western countries ranges from 300,000 to 400,000 annually, which represents 0.36 to 1.28 per 1 000 inhabitants in Europe and the United States.
View Article and Find Full Text PDFRev Prat
February 2013
Service d'urologie, Centre hospitalier Victor-Provo, 59100 Roubaix, France.
Rev Prat
December 2008
Service d'urologie, centre hospitalier Victor-Provo, 59100 Roubaix, France.
Arch Pediatr
January 2007
Service de pédiatrie, pavillon de pédiatrie médicochirurgical, centre hospitalier Victor-Provo, 59056 Roubaix cedex 01, France.
Prog Urol
April 2003
Service d'Urologie, Centre Hospitalier Victor Provo, Boulevard Lacordaire, BP 359, 59056 Roubaix, France.
Objective: Urothelial bladder tumours are rare before the age of 40 and represent only 1% to 4% of all bladder tumours. This study reviews the histological features of these tumours and tries to more clearly define their natural history.
Material And Method: From 1980 to 2000, we observed 2,600 cases of primary bladder tumours; 34 subjects were younger than 40.
Cah Anesthesiol
July 1993
Service d'Anesthésie-réanimation, Centre hospitalier Victor-Provo, Roubaix.
We studied the usefulness of plasma D-dimer determination by a latex agglutination test used as a deep venous thrombosis (DVT) detection method in patients undergoing recent orthopaedic or traumatologic surgery. Asymptomatic patients with a level of D-dimer up to 1.5 micrograms/ml suffered phlebographic venous thrombosis in 49.
View Article and Find Full Text PDFCah Anesthesiol
November 1990
Service d'Anesthésie-Réanimation, Centre Hospitalier Victor-Provo, Roubaix.
A routine method of prophylaxis of thromboembolic disease is evaluated on 181 elderly patients undergoing post-traumatic hip surgery. A low incidence of proximal thrombosis and fatal embolism is noted and rated as a beneficial effect of the association of low molecular weight heparin therapy and moderate hemodilution; it is also connected with a precocious diagnosis of the thrombotic complications--before the proximal extension of silent thromboses--by the measurement of specific fibrin derivatives used as a screening technique in order to select the patients who will have to undergo venographical examination.
View Article and Find Full Text PDFCah Anesthesiol
October 1990
Service d'Anesthésie Réanimation, Centre Hospitalier Victor Provo, Roubaix.
Cah Anesthesiol
November 1990
Service d'Anesthésie-Réanimation, Centre hospitalier Victor-Provo, Roubaix.
Cah Anesthesiol
November 1989
Service d'Anesthésie-Réanimation, Centre hospitalier Victor-Provo, Roubaix.